NDC 68180-0513 - Lisinopril and hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68180-0513
- Manufacturer
- State of Florida DOH Central Pharmacy
- Effective date
- 2010-06-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Lisinopril and hydrochlorothiazide - State of Florida DOH Central Pharmacy | State of Florida DOH Central Pharmacy | 2010-06-07 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Mannitol | MANNITOL | Henry Schein, Inc. | e2444db1-9dfe-451f-a33c-9b00786464d2 | 2025-05-20 | Warnings, Adverse reactions | 3OWL53L36A |
| Candesartan Cilexetil and Hydrochlorothiazide | CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE | Macleods Pharmaceuticals Limited | 76630807-9717-44be-946d-756038cf677e | 2025-05-15 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 02a481cb-ad80-41bb-82d3-c237b00ed8d7 | 2025-05-15 | Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 1570f1ad-8372-477f-89c3-8c9ce01e27d1 | 2025-05-07 | Warnings, Adverse reactions | 0J48LPH2TH |
| LISINOPRIL | LISINOPRIL | Asclemed USA, Inc. | db5bfa2f-07b8-4f79-8a40-691da006e2ed | 2025-05-02 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Preferred Pharmaceuticals Inc. | 82ad0fdf-5d47-4c2d-883b-f28b2d3fb6b0 | 2025-04-29 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals,Inc. | fea5a353-9b13-9b87-e053-6394a90a627d | 2025-04-25 | Warnings, Adverse reactions | 0J48LPH2TH |
| LISINOPRIL | LISINOPRIL | PD-Rx Pharmaceuticals, Inc. | bf59ff89-a9fa-4fe3-b167-a5d0cba9e438 | 2025-04-11 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| LISINOPRIL | LISINOPRIL | PD-Rx Pharmaceuticals, Inc. | 03a497fe-fb09-4b2c-8ee0-2019600192b8 | 2025-04-11 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| LISINOPRIL | LISINOPRIL | PD-Rx Pharmaceuticals, Inc. | dd015c18-1ea6-44e3-9186-8d2f8444d874 | 2025-04-11 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| LISINOPRIL | LISINOPRIL | PD-Rx Pharmaceuticals, Inc. | e4c11545-00da-4675-856a-7e600a2f4bd9 | 2025-04-11 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | NorthStar RxLLC | 364af4fe-cde8-466f-b56f-d93d532b56f5 | 2025-04-10 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| AMLODIPINE, VALSARTAN, HYDROCHLOROTHIAZIDE | AMLODIPINE BESYLATE VALSARTAN HYDROCHLOROTHIAZIDE | Strides Pharma Science Limited | 9b76e441-e6a5-4036-8276-b7788ade5c44 | 2025-04-10 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril | LISINOPRIL | Bryant Ranch Prepack | cced442b-8047-4489-95d6-0700a66fba34 | 2025-04-03 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| Zestoretic | LISINOPRIL AND HYDROCHLOROTHIAZIDE | Almatica Pharma Inc. | 0d3a966f-f937-05a8-a90f-5aa52ebbd613 | 2025-03-31 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Macleods Pharmaceuticals Limited | e05e3314-5520-4bbd-b7f0-623afd9ba569 | 2025-03-04 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals,Inc. | 852c6f3f-d3f5-0d99-e053-2991aa0aa9c3 | 2025-02-21 | Warnings, Adverse reactions | 0J48LPH2TH |
| LISINOPRIL and HYDROCHLOROTHIAZIDE | LISINOPRIL AND HYDROCHLOROTHIAZIDE | GSMS, Incorporated | d02a0d38-676a-4e0f-9aa2-0a6c56cd7361 | 2025-02-15 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR 0J48LPH2TH |
| Lisinopril | LISINOPRIL | NuCare Pharmaceuticals,Inc. | fbd3bde1-ee64-126f-e053-6394a90a9b6d | 2025-02-05 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| Lisinopril | LISINOPRIL | NuCare Pharmaceuticals,Inc. | fbfa23c2-dae0-4f45-e053-6394a90a4fef | 2025-02-05 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.